搜索临床试验以:Omega-3-酸乙酯 90 (TAK-085)
总计101个结果
-
AstraZeneca完全的2型糖尿病 | 外分泌性胰腺功能不全瑞典, 波兰, 拉脱维亚, 丹麦, 匈牙利, 斯洛伐克
-
Pronova BioPharmaDanish Heart Foundation; The Danish Kidney Association; North Jutland County完全的
-
EnzymotecDaewon Pharmaceutical Co., Ltd.完全的
-
Pronova BioPharmaAalborg University Hospital完全的
-
United States Department of DefenseGlaxoSmithKline未知
-
Beth Israel Deaconess Medical CenterNational Heart, Lung, and Blood Institute (NHLBI); Tufts Medical Center完全的
-
Olive View-UCLA Education & Research InstituteReliant Pharmaceuticals完全的
-
Babu BalagopalJohns Hopkins University; GlaxoSmithKline; Thomas Jefferson University完全的
-
University of Kansas Medical Center主动,不招人
-
Brigham and Women's HospitalNational Institute of General Medical Sciences (NIGMS)完全的
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKline完全的
-
Milton S. Hershey Medical CenterGlaxoSmithKline; The American Society of Cataract and Refractive Surgery Foundation完全的
-
Eastern Virginia Medical SchoolGlaxoSmithKline完全的
-
Tufts University完全的
-
Milton S. Hershey Medical Center撤销
-
Matinas BioPharma Nanotechnologies, Inc.MB Clinical Research and Consulting LLC; Matinas Biopharma, Inc完全的
-
Massachusetts General HospitalHarvard School of Public Health (HSPH)撤销
-
H. Lee Moffitt Cancer Center and Research InstituteUniversity of South Florida; Gateway for Cancer Research完全的
-
AstraZeneca完全的
-
Universidade Nova de LisboaCentro de Investigação Operacional da Beira, Mozambique; Fundação Belmiro de Azevedo, Portugal主动,不招人
-
GlaxoSmithKline完全的
-
University of OxfordBayer; Medical Research Council; Abbott; British Heart Foundation; Solvay Pharmaceuticals; The Macular... 和其他合作者主动,不招人